Your browser doesn't support javascript.
loading
Combined Transplantation of Human MSCs and ECFCs Improves Cardiac Function and Decrease Cardiomyocyte Apoptosis After Acute Myocardial Infarction.
Tripathi, Himi; Domingues, Alison; Donahue, Renee; Cras, Audrey; Guerin, Coralie L; Gao, Erhe; Levitan, Bryana; Ratajczak, Mariusz Z; Smadja, David M; Abdel-Latif, Ahmed; Tarhuni, Wadea M.
Afiliación
  • Tripathi H; Gill Heart and Vascular Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY, USA.
  • Domingues A; Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.
  • Donahue R; Université de Paris, INSERM, Innovative Therapies in Haemostasis, 75006, Paris, France.
  • Cras A; Gill Heart and Vascular Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY, USA.
  • Guerin CL; Université de Paris, INSERM, Innovative Therapies in Haemostasis, 75006, Paris, France.
  • Gao E; Cell Therapy Department, AP-HP, Hôpital Saint Louis, 75010, Paris, France.
  • Levitan B; Université de Paris, INSERM, Innovative Therapies in Haemostasis, 75006, Paris, France.
  • Ratajczak MZ; Curie Institute, Paris, France.
  • Smadja DM; The Center for Translational Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
  • Abdel-Latif A; Gill Heart and Vascular Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY, USA.
  • Tarhuni WM; Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Stem Cell Rev Rep ; 19(2): 573-577, 2023 02.
Article en En | MEDLINE | ID: mdl-36271311

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas / Infarto del Miocardio Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Stem Cell Rev Rep Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas / Infarto del Miocardio Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Stem Cell Rev Rep Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos